CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

gsk-690693

Small moleculeexperimental

Clinical trial activity

2 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2007 (NCT00493818)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21
Mol. weight
425.49 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • gsk690693
  • gsk690693
  • gsk690693
  • gsk-690693
  • gsk-690693
  • gsk-690693

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00666081Phase 1Apr 1, 2008GlaxoSmithKline
NCT00493818Phase 1Apr 1, 2007GlaxoSmithKline
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GlaxoSmithKlineFor profit2212007
1 organizations
Page 1 / 1